. FDA considers Alzheimer's drug previously abandoned for lack of effectiveness. BMJ. 2019 Oct 23;367:l6164. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.